The new report by Expert Market Research titled, ‘Global Malignant Mesothelioma Therapeutics Market Size, Share, Report and Forecast 2023-2028’, gives an in-depth analysis of the global malignant mesothelioma therapeutics market, assessing the market based on its segments like products, application, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin America. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/malignant-mesothelioma-therapeutics-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 7.4%
The growth of global malignant mesothelioma therapeutics industry is driven by the rising incidence of malignant mesothelioma among individuals. The increasing awareness about cancer and its effective treatment therapies among individuals are expected to aid the market growth. Additionally, various screening initiatives by government and private organisations for monitoring health of workers in asbestos using industries are expected to push the market growth. Moreover, the research and development (R&D) activities for advance treatment options and novel therapies will likely bolster the market growth over the forecast period.
Industry Definition and Major Segments
Malignant mesothelioma refers to cancerous tumour occurring in the thin lining known as epithelium. The tumour is commonly found in heart, stomach, or lungs. The primary cause of mesothelioma is inhalation of asbestos. Malignant mesothelioma is majorly prevalent in geriatric male population. The most common treatment procedure includes chemotherapy along with surgery and radiotherapy.
Explore full report with table of contents: https://www.expertmarketresearch.com/reports/malignant-mesothelioma-therapeutics-market
Based on types, the industry is divided into:
- Other Therapeutics
The industry can be broadly categorised based on its application into:
- Hospital Pharmacies
- Retail Pharmacies
- Oncology Centres
The regional markets for malignant mesothelioma therapeutics include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Regionally, North America is expected to dominate the global market for malignant mesothelioma owing to the growing prevalence of malignant mesothelioma. Europe may likely follow the North America due to vast geriatric population and demand for advance cancer treatment therapies. Meanwhile, Asia Pacific is expected to witness the fastest growth rate over the forecast period. This can be attributed to the rapidly advancing healthcare industry, rising patient awareness and growing government initiatives. However, Latin America and Middle East and Africa are projected for a slow growth due to high cost of therapy and lack of patient awareness.
Key Market Players
The major players in the market are Bristol-Myers Squibb Co. (NYSE: BMY), Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc. and few others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Mathew Williams, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA